PLAC8 encodes a 115-amino-acid protein (UniProt: Q9NZF1) localized to cytoplasmic granules and extracellular regions . Key features include:
| Attribute | Details |
|---|---|
| Chromosomal Location | 4q21.21 |
| Aliases | C15, ONZIN, DGIC |
| Molecular Function | Chromatin binding, immune modulation |
| Pathway Involvement | Innate Immune System, Autophagy, ERK |
| Disease Associations | Sepsis, COVID-19, Cancer, Preeclampsia |
PLAC8 modulates monocyte survival and cytokine production via the ERK pathway, as demonstrated in LPS-induced sepsis models :
| Parameter | PLAC8 Overexpression | PLAC8 Knockdown |
|---|---|---|
| Monocyte Proliferation | ↑ 1.8-fold | ↓ 60% |
| TNF-α/IL-6 Levels | ↑ 2.5-fold | ↓ 55% |
| ERK Phosphorylation | ↑ 3.1-fold | ↓ 70% |
Mechanism: PLAC8 enhances ERK1/2 phosphorylation, driving CD14/CD16 expression and pro-inflammatory cytokine release .
PLAC8 facilitates pancreatic SARS-CoV-2 infection by enabling viral entry and replication :
| Cell Type | Infection Rate (WT vs. PLAC8-KO) |
|---|---|
| PDAC Cell Lines | 85% ↓ (Wuhan-1 strain) |
| Beta Cell-Derived Lines | 78% ↓ (BA.1 variant) |
Key Findings:
PLAC8 expression correlates with SARS-CoV-2 nucleocapsid levels in pancreatic autopsies .
CRISPR/Cas9 knockout reduces pseudovirus infection by 90% in human beta cells .
PLAC8 is upregulated in multiple cancers and influences tumor immunity :
| Cancer Type | Role | Clinical Relevance |
|---|---|---|
| Clear Cell RCC | Immune microenvironment remodeling | ↑ PD-L1 expression; poor prognosis |
| Triple-Negative Breast | UFM1-mediated stabilization | Correlates with tumor grade (p<0.01) |
| Pancreatic Ductal | Autophagy regulation | Linked to chemoresistance |
Mechanistic Insight: In breast cancer, PLAC8 stabilizes PD-L1 via reduced ubiquitination, promoting immune evasion .
PLAC8 is critical for trophoblast migration in placental development :
| Parameter | Normal Trophoblasts | Preeclamptic Trophoblasts |
|---|---|---|
| PLAC8 Expression | Moderate | ↑ 3.2-fold |
| Migration Rate | 42 μm/hour | ↓ 65% |
Pathway: PLAC8 activates Cdc42/Rac1 GTPases, inducing filopodia formation .
PLAC8 interacts with immune and transcriptional regulators :
| Interacting Protein | Function |
|---|---|
| POLR3H | RNA polymerase III; viral DNA sensing |
| PLSCR1 | Phospholipid scramblase activity |
| CNOT11 | mRNA deadenylation |
PLAC8 is a relatively small protein with diverse and context-dependent functions across different cell types. Initially identified in placental tissue, it has emerged as a multifunctional protein involved in various cellular processes. The cellular role of PLAC8 is highly variable, with sometimes contradictory effects observed in different cell types .
Research has revealed several key functions:
Regulation of autophagy and lysosomal function, particularly in cancer cells where it facilitates lysosome-autophagosome fusion
Modulation of immune responses, including monocyte proliferation and activation during sepsis
Involvement in cell migration and invasion, especially in trophoblast and cancer cells
Contribution to radioresistance mechanisms through effects on DNA repair pathways
In terms of molecular mechanisms, PLAC8 has been shown to interact with various signaling pathways, including ERK signaling that affects downstream cellular processes like proliferation and activation .
PLAC8 expression patterns vary significantly across tissues and physiological conditions:
In placental tissue, PLAC8 shows a highly specific expression pattern, being exclusively expressed in interstitial extravillous trophoblast cells (iEVTs) but not in other trophoblast subtypes, making it a specific marker for iEVTs
Expression increases from the proximal region of the trophoblast cell column to the distal region in early placental development
Oxygen tension significantly influences PLAC8 expression, with hypoxic conditions (2% oxygen) substantially increasing PLAC8 levels compared to normoxic conditions (20% oxygen)
In cancer tissues, PLAC8 is often upregulated, particularly in metastatic cells compared to primary tumor cells, as observed in colorectal cancer cell lines
A critical regulatory mechanism for PLAC8 appears to be cellular differentiation. During the differentiation of cytotrophoblasts (CTBs) into iEVTs, PLAC8 expression is strongly induced and progressively increases throughout this process .
PLAC8 has been identified as an essential host factor for certain coronavirus infections:
Genomewide CRISPR knockout screening identified PLAC8 as a crucial host factor for swine acute diarrhea syndrome coronavirus (SADS-CoV) infection
Knockout of PLAC8 abolished SADS-CoV infection, which could be restored by complementing PLAC8 from multiple species (human, rhesus macaques, mouse, pig, pangolin, and bat)
Mechanistically, PLAC8 knockout does not affect viral entry but rather leads to a delay and reduction in viral subgenomic RNA expression
This conservation of PLAC8 function across species suggests a common infection pathway and indicates potential susceptibility to SADS-CoV among various mammals, including humans . The finding has significant implications for pandemic preparedness, as SADS-CoV can infect human primary cultures without adaptation.
For researchers studying emerging viral threats, PLAC8 represents a novel antiviral target that may be relevant not only for SADS-CoV but potentially for other coronavirus infections as well.
In sepsis, PLAC8 plays a critical role in regulating monocyte function:
It promotes monocyte survival, proliferation, and activation through the ERK pathway
PLAC8 upregulation leads to increased phosphorylation of ERK protein and elevated levels of monocyte markers (CD14, CD16) and pro-inflammatory cytokines (TNF-α, IL-6, IL-10)
Experimental data from both in vitro lipopolysaccharide-stimulated monocytes and murine sepsis models (cecal ligation and puncture) demonstrate that Plac8 overexpression activates the ERK pathway, contributing to the dysregulated immune response characteristic of sepsis .
The Plac8-ERK pathway thus represents a potential therapeutic target for modulating immune responses in sepsis patients, where controlling excessive monocyte activation could improve clinical outcomes.
PLAC8 has emerged as a significant factor in cancer biology with multiple roles:
In pancreatic ductal adenocarcinoma (PDA), PLAC8 is synergistically activated by combined RAS and p53 mutations, serving as a downstream mediator of tumorigenesis
shRNA-mediated knockdown of PLAC8 virtually abolished tumorigenicity of multiple human PDA cell lines (CAPAN-2, Panc-1, and Panc10.05) when implanted into immunocompromised mice
In colorectal cancer, higher PLAC8 levels are observed in metastatic cell lines compared to their primary counterparts (SW620 vs. SW480, KM12SM vs. KM12C)
PLAC8 overexpression increases tumor cell growth and invasion capabilities
These findings indicate that PLAC8 is not merely a biomarker but an active contributor to cancer progression, particularly in pancreatic and colorectal cancers. The correlation between PLAC8 levels and metastatic potential suggests its potential utility as a prognostic marker.
PLAC8 serves as a critical regulator of autophagy, particularly in pancreatic cancer:
PLAC8 provides a mechanistic link between primary oncogenic mutations (p53 and RAS) and the induction of autophagy, a central mechanism of metabolic reprogramming during pancreatic cancer progression
It functions as a critical regulator of the autophagic machinery by localizing to the lysosomal compartment and facilitating lysosome-autophagosome fusion
This autophagy regulation is essential for maintaining metabolic homeostasis in pancreatic ductal adenocarcinoma
The connection between PLAC8, autophagy, and cancer progression reveals why PLAC8 is essential for the cancer phenotype in multiple human PDA cell lines. By facilitating autophagy, PLAC8 helps cancer cells survive in nutrient-poor and stressful tumor microenvironments.
PLAC8 contributes significantly to radioresistance in cancer cells:
Knockout of PLAC8 enhances the radiosensitivity of cancer cells in vitro
PLAC8 knockout decreases proliferation and colony-forming ability of irradiated cells
Mechanistically, PLAC8 knockout affects several key processes:
These findings suggest that targeting PLAC8 could potentially enhance the efficacy of radiation therapy in cancer treatment. The increase in DNA damage markers and apoptotic indicators after PLAC8 knockout indicates that PLAC8 normally functions to protect cancer cells from radiation-induced damage.
PLAC8 has been identified as a highly specific marker for interstitial extravillous trophoblast (iEVT) cells in human placenta:
PLAC8 is exclusively expressed in the trophoblast cell column in early placental villi, with increasing expression from the proximal to distal regions
It is specifically expressed in iEVTs that have invaded and migrated into the uterine wall but is absent in maternal decidual cells
In broad confocal scanning of placental sections, all iEVTs at the maternal side of the fetomaternal interface display strong PLAC8 signals
This specificity makes PLAC8 a valuable marker for identifying and studying iEVTs in placental research. The exclusive expression in iEVTs but not in other trophoblast subtypes suggests that PLAC8 may have a functional role specifically related to the invasive properties of these cells.
PLAC8 plays a critical role in promoting trophoblast invasion and migration through specific molecular mechanisms:
Time-lapse imaging, GTPase activity assays, co-immunoprecipitation, and RNA-seq studies demonstrate that PLAC8 increases Cdc42 and Rac1 activities
PLAC8 induces the formation of filopodia at the leading edge of migratory trophoblast cells
Expression of PLAC8 is significantly upregulated under hypoxic conditions, which is relevant to early placental development
Notably, PLAC8 expression is higher in iEVTs from preeclamptic placentas compared to normal control placentas, suggesting potential involvement in placental pathologies
The regulatory role of PLAC8 in trophoblast invasion is particularly significant given that proper trophoblast invasion is essential for normal placental development and pregnancy outcomes. The connection to preeclampsia points to potential clinical applications in monitoring and managing pregnancy complications.
Based on the reviewed literature, several effective experimental approaches for studying PLAC8 function include:
CRISPR/Cas9 Knockout Systems:
Cellular Models:
Primary cell cultures: Swine primary intestinal epithelial cultures (IECs) have proven useful for studying PLAC8 in the context of viral infection
Cancer cell lines: Human PDA cell lines (CAPAN-2, Panc-1, Panc10.05) and colorectal cancer lines (SW620, SW480) for studying PLAC8 in cancer
Trophoblast differentiation models:
Functional Assays:
Molecular Techniques:
Oxygen Tension Manipulation:
These methodologies can be combined to comprehensively understand PLAC8's multifaceted roles in different cellular contexts.
Several methodological challenges need to be addressed when studying PLAC8:
Context-Dependent Functions:
Regulation by Microenvironmental Factors:
Differentiation State Sensitivity:
Technical Challenges:
Translational Relevance:
Bridging findings from cell culture to in vivo significance requires appropriate animal models and potentially validation in human samples
Patient-derived samples or organoids may provide more physiologically relevant contexts
Addressing these challenges through rigorous experimental design and appropriate controls will enhance the reliability and translational value of PLAC8 research.
Several promising research directions for PLAC8 include:
Pandemic Preparedness:
Cancer Therapeutics:
Immune Modulation:
Reproductive Medicine:
Mechanistic Studies:
Structural Biology:
Determination of PLAC8's three-dimensional structure to facilitate structure-based drug design
Characterization of its protein-protein interaction interfaces
These research directions could significantly advance our understanding of PLAC8 biology and lead to novel diagnostic and therapeutic approaches.
Integrated multi-omics approaches offer powerful ways to advance PLAC8 research:
Transcriptomics + Proteomics:
Combining RNA-seq with proteomics can reveal discrepancies between mRNA and protein levels of PLAC8 and related genes
This integrated approach can identify post-transcriptional regulatory mechanisms affecting PLAC8 expression
Functional Genomics + Interactomics:
Epigenomics + Transcriptomics:
Single-Cell Approaches:
Single-cell RNA-seq and proteomics could reveal heterogeneity in PLAC8 expression and function within tissues
Particularly valuable for studying PLAC8 in complex tissues like tumors and placenta
Spatial Transcriptomics:
These integrated approaches would provide a more comprehensive understanding of PLAC8 biology across different physiological and pathological contexts, potentially revealing new therapeutic opportunities.
The PLAC8 protein contains five exons, coding for an mRNA species of 829 base pairs and an open reading frame of 115 amino acids . This protein shows a high degree of conservation (83%) between humans and mice . PLAC8 is expressed at high levels in various tissues, including plasmacytoid dendritic cells, spleen, lymph nodes, peripheral blood leukocytes, and bone marrow .
PLAC8 plays multifaceted roles in both normal physiological processes and pathological conditions:
Pregnancy and Placental Development: PLAC8 expression is dynamic during pregnancy and placental development, accumulating in an implantation-dependent manner . It is highly expressed in the endometrium of pregnant cows compared to nonpregnant cows and is upregulated in blastocysts, contributing to calf delivery .
Embryo Development: PLAC8 is involved in the differentiation process of cytotrophoblast cells into interstitial extravillous trophoblast cells . It has been found to be involved in organ development and is a molecular marker to predict prognosis and distinguish between different cell subpopulations .
Cancer: The role of PLAC8 in tumorigenesis has been gradually elucidated. It impacts tumorigenesis in varied ways, sometimes having opposite effects on cancer progression . PLAC8’s molecular functions in cancer include enforcing cell growth and influencing different stages of cancer progression . Understanding these roles can lead to the development of novel anticancer therapies .
Recombinant human PLAC8 protein, fused to a His-tag at the N-terminus, is expressed in E. coli . This recombinant protein is used for research purposes and is not approved for clinical use in humans . It is typically used in Western Blot (WB) or imaging assays .
Storage and Handling: The recombinant human PLAC8 protein should be stored at 4°C for short-term use and at -20°C for long-term storage. It is important to avoid freeze-thaw cycles to maintain its stability .